NDC 0006-3026 – Keytruda
Pembrolizumab 25 mg/mL · Injection, Solution · Intravenous
Product NDC0006-3026
Product details
- Brand name
- Keytruda
- Generic name
- Pembrolizumab
- Labeler
- Merck Sharp & Dohme LLC
- Dosage form
- Injection, Solution
- Route
- Intravenous
- Marketing category
- BLA · BLA125514
- Marketed since
- January 15, 2015
- Listing expires
- December 31, 2027
- Pharmacologic class
- Programmed Death Receptor-1 Blocking Antibody
Active ingredients
- Pembrolizumab 25 mg/mL
Package NDC codes (2)
| Package NDC | Description | Since |
|---|---|---|
| 0006-3026-02 | 1 VIAL in 1 CARTON (0006-3026-02) / 4 mL in 1 VIAL (0006-3026-01) | Jan 15, 2015 |
| 0006-3026-04 | 2 VIAL in 1 CARTON (0006-3026-04) / 4 mL in 1 VIAL (0006-3026-01) | Aug 1, 2019 |